Robert Bayer

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Pamela B. Allen, Hatice Savas, Andrew M. Evens et al. · Blood · 2020 · 135 citations · Full text

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.

Patrick J. Stiff, Robert Bayer, C. Kerger et al. · Journal of Clinical Oncology · 1997 · 121 citations

Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.

Jeffrey H. Kordower, Vincent Charles, Robert Bayer et al. · Proceedings of the National Academy of Sciences · 1994 · 120 citations

Intravenous Administration, Neuroinflammation, Neurology +16

Recombinant Methionyl Human Stem Cell Factor and Filgrastim for Peripheral Blood Progenitor Cell Mobilization and Transplantation in Non-Hodgkin's Lymphoma Patients — Results of a Phase I/II Trial

Craig H. Moskowitz, Patrick J. Stiff, Michael S. Gordon et al. · Blood · 1997 · 101 citations

Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer

Patrick J. Stiff, Bohao Chen, Wilbur A. Franklin et al. · Blood · 2000 · 91 citations